Diagnosticos da America

What Diagnosticos da America does

DASA (Diagnosticos da America S/A) is the largest diagnostic medicine company in Brazil and a leading player in Latin America, publicly traded on B3 under ticker DASA3 with corporate headquarters in Alphaville, Barueri (Sao Paulo). The company operates an integrated diagnostic platform spanning clinical laboratory analysis, diagnostic imaging, anatomical pathology, and genomic medicine, delivered through 850+ diagnostic units under 40+ laboratory and medical center brands including Delboni, Sergio Franco, Bronstein, and Alta Diagnosticos. DASA processes over 400 million exams annually, serves more than 20 million patients, and partners with 350,000+ physicians across Brazil, with international operations in Uruguay, Argentina, Chile, and Colombia. The platform is supported by 4,500+ diagnostic imaging devices and AI-powered algorithms for radiology interpretation, polygenic risk scores for predictive genomics (prostate cancer, coronary artery disease), and the Nav Dasa digital patient platform for appointment scheduling, telemedicine, and medical history access.

DASA generates revenue through multiple streams: transaction-fee diagnostic services (the core), subscription revenue from the Cartao Dasa +Saude health discount card launched in November 2025 (plans from R$9.90/month), enterprise B2B contracts for occupational health, vaccination campaigns, toxicology testing, and executive check-ups, plus hospital and oncology services through wholly-owned facilities including Hospital Sao Domingos and Hospital Leforte. The Alvaro Apoio B2B unit operates six nationwide mega Technical-Operational Centers providing outsourcing services to other laboratories, clinics, and hospitals. DASA also runs the StartupLab open innovation program and Dasa Pulsa startup accelerator to source healthtech partnerships, and operates the Dasa Educa medical education platform alongside clinical research through the Instituto de Ensino e Pesquisa Dasa (IEPD).

DASA's competitive position rests on scale-driven cost advantages, a vast clinical data corpus enabling AI diagnostic development, and an entrenched physician referral network. Recent strategic emphasis has shifted toward operational turnaround: FY2025 free cash flow rose 75.3% to R$651 million, recurring EBITDA in Q4 2025 grew 21% to R$397 million, and leverage improved from 3.5x to 2.5x. The company is accredited under JCI, PALC, CAP, Qmentum Diamond, and HIMSS Stage 7, and was included in the B3 Corporate Sustainability Index in 2023.

Name

Diagnosticos da America

Legal name

Diagnósticos da América S/A

Website

https://dasa.com.br

Company type

Public

Founded year

1990

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

DASA (Diagnosticos da America) is the largest diagnostic medicine network in Latin America, operating 850+ units under 40+ brands in Brazil, Uruguay, Argentina, Chile, and Colombia. It processes 400+ million exams annually for 20+ million patients, partnering with 350,000+ physicians.

Ownership category

akta.pro rank

Product category

Diagnostic Medicine Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071), Services-Health Services (8000)

akta.pro primary industry

Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA)

akta.pro secondary industries

Quality, Peer Review & Compliance Tools (MQSA/ACR/QA) (HLACALAL), Real-World Data (RWD) Platforms & Clinical Data Curation (HLACAIAJ)

Keywords

• Diagnostic medicine services
• Clinical laboratory analysis
• Medical imaging diagnostics
• Genomic medicine testing
• Corporate health programs

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Diagnostic Services: Core laboratory diagnostic services including clinical analysis, medical imaging, pathology and genetic testing through network of 850+ units
2. Dasa +Saude Subscription Card: Annual subscription health discount card offering up to 60% discounts on exams, consultations, vaccines and medications. Plans from R$9.90/month
3. Corporate Health Services: Enterprise solutions including occupational vaccination campaigns, toxicological testing, executive health check-ups, and telemedicine for corporate clients
4. Hospital and Oncology Services: Integrated hospital and oncology care vertical with growing revenue contribution

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

Diagnosticos da America (DASA) is the largest diagnostic medicine network in Latin America, operating 850+ diagnostic units across Brazil under 40+ laboratory and medical center brands. The company delivers clinical analysis, diagnostic imaging with AI-powered algorithms, anatomical pathology, and genomic medicine (through Dasa Genomica combining GeneOne, Chromosome, Genia and Insitus), supported by a digital care platform (Nav Dasa) and corporate health services including vaccination campaigns, toxicology testing and executive check-ups.

Product overview

DASA (Diagnósticos da América) operates as an integrated healthcare company combining diagnostic medicine, integrated care management, and healthcare innovation. The core offering centers on Medicina Diagnóstica (Diagnostic Medicine) — encompassing Análises Clínicas (clinical laboratory analysis), Diagnóstico por Imagem (AI-powered diagnostic imaging with 4,500+ pieces of equipment), Patologia (anatomical pathology), and Genética (Dasa Genômica genomic medicine). Supporting services include Imunização (vaccination), Cuidados Integrados (multidisciplinary care management), Pesquisa Clínica (clinical research), and B2B corporate services (vacinations, toxicology testing, executive check-ups). DASA also offers the Dasa +Saúde benefit card for patient discounts, the Nav Dasa digital care platform, and operates innovation programs (StartupLab, Dasa Pulsa) connecting healthtech startups. The company comprises over 40 laboratory and medical center brands across Brazil, processing over 400 million tests annually with partnerships with 350,000+ physicians.

Differentiator

Problem solved

Functional benefit

Brands

• Nav Dasa: Digital platform for online medical appointments, exam scheduling and medical history access
• Dasa Genômica
• Dasa Oncologia
• Dasa Educa
• StartupLab
• Dasa Pulsa
• Alvaro Apoio
• Cartão Dasa +Saúde
• Genov
• NAM – Núcleo de Assessoria Médica

Products and services

• Análises Clínicas (Clinical Laboratory Analysis) Reference clinical laboratory diagnostics service with 18 technical-operational nuclei and specialists delivering integrated care across all stages of laboratory medicine for patients across Brazil.
• Diagnóstico por Imagem (Diagnostic Imaging)

Quantifiable outcome

• 20+ million patients served annually
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability14 records

Feature3 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Instituto Ekos BrasilcoreStrategic or Co-development Partner · 1 January 2022DASA became a supporter of Instituto Ekos Brasil and joined the Climate Commitment Program (Programa Compromisso com o Clima), aimed at advancing climate change combat efforts. The partnership enables access to a digital platform with portfolio of carbon credit projects for emissions compensation.
• InnoscienceminorImplementation/ SI/ Consulting PartnerInnoscience is a Corporate Innovation Consulting firm that brings knowledge, method and experiences to support established companies in generating results and profiting from innovation. Partnered with DASA on the StartupLab program.
• Ministry of Health (Brazil)coreStrategic or Co-development PartnerDASA partnered with the Brazilian Ministry of Health to create a specialized emergency laboratory for COVID-19 testing, processing up to 3 million RT-PCR tests over six months. DASA donated processing of tests and provided infrastructure and 120 professionals.
• RSNA (Radiological Society of North America)minorStrategic or Co-development PartnerCollaboration with RSNA on AI challenges and publishing of medical imaging datasets including the LumbarDISC dataset for degenerative spine classification.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Eurofins Scientific: Global bioanalytical testing group operating clinical diagnostics, pharma services, and food/environmental testing across 60+ countries. Comparable to DASA's B2B Alvaro Apoio unit and broader clinical diagnostics, though broader in scope.
• Quest Diagnostics: US-based clinical laboratory leader offering routine and esoteric testing, with advanced diagnostics and consumer-initiated testing. Comparable to DASA in core lab operations, though US-focused and operating at much larger scale with broader payer mix.
• Sonic Healthcare: Australia-headquartered global diagnostics operator with labs, imaging, and pathology services across Australia, Europe, and North America. Comparable to DASA in multi-country lab operations and physician-focused service model.
• Laboratory Corporation of America (Labcorp): Global clinical laboratory and diagnostics provider with US reference lab, early development services, and consumer testing. Comparable to DASA in routine and specialty diagnostics, though far larger and more diversified across drug development.

Direct peers

• Alliar: Brazilian diagnostic medicine network built through regional lab acquisitions across multiple states. Competes directly with DASA on clinical analysis, imaging, and outpatient diagnostic services in overlapping geographies.
• Hermes Pardini: Brazilian reference laboratory offering clinical analysis, specialized testing, and genomic services with a strong brand in Minas Gerais. Comparable to DASA in specialty diagnostics and reference testing capabilities.
• Synlab: Europe's largest medical diagnostics provider operating clinical labs, imaging, and specialty diagnostics across 30+ countries. Comparable to DASA in business model of multi-brand regional lab networks serving physicians and patients.
• Fleury: Brazil's other leading diagnostic medicine network offering clinical analysis, imaging, pathology, and genomics to patients and physicians nationwide. Fleury is DASA's primary direct competitor with similar brand portfolio strategy and premium positioning.
• Unilabs: European diagnostics operator (private-equity owned) providing clinical laboratory, imaging, and specialty diagnostics across multiple countries. Comparable scale and operating model to DASA's multi-brand regional lab network.

Emerging players

• Rede D'Or São Luiz: Brazil's largest private hospital network increasingly integrating diagnostic services within its facilities. Adjacent competitor to DASA in hospital-based diagnostic services and integrated care, though hospital-led rather than lab-led.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCjwXYCP6snqEnOglze3Xs4A
• Facebookfacebook.com/Dasa
• LinkedInlinkedin.com/company/dasa
• Instagraminstagram.com/dasa.oficial

Compliance17 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries16 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Diagnosticos da America